DNA Genetics was founded in Amsterdam in the early 2000s by two California-based cannabis enthusiasts, Don and Aaron Morris, who brought their OG Kush genetics to the Netherlands and established one of the most respected breeding programmes in the cannabis world. Their access to verified OG Kush genetics — at a time when authentic OG material was extremely difficult to source outside California — gave them a breeding advantage that translated into a catalogue of OG-based hybrids that have won dozens of Cannabis Cup awards.
Kushberry represents the combination of DNA Genetics’ OG Kush work with one of cannabis’s most iconic berry strains. DJ Short’s Blueberry, the other parent, is a legendary indica-dominant hybrid created by American breeder DJ Short (Doug) in the 1970s from Thai, Purple Thai, and Afghani genetics. Blueberry won the High Times Cannabis Cup for Best Indica in 2000 and remains the reference point for berry-flavoured cannabis genetics worldwide. The combination of OG Kush depth and Blueberry sweetness creates a flavour and effect profile that has been attempted by dozens of breeders — Kushberry by DNA Genetics is considered one of the most successful executions.
The indica dominance (approximately 70%) comes primarily from the Blueberry parent, which itself carries significant Afghani landrace indica genetics. The OG Kush contribution (believed to be a Chemdawg × Hindu Kush × Lemon Thai cross) adds a cerebral dimension and the characteristic kush body depth that distinguishes Kushberry from purely fruity berry strains.
| Generation | Strain | Contributing Genetics | Key Trait Contribution |
|---|---|---|---|
| Grandparent | Afghani | Hindu Kush landrace | Indica structure, resin, sedation (via Blueberry) |
| Grandparent | Thai / Purple Thai | Southeast Asian sativa | Berry aroma, purple colour (via Blueberry) |
| Parent 1 | OG Kush | Chemdawg × Hindu Kush × Lemon Thai | Earthy-fuel depth, cerebral euphoria, kush body |
| Parent 2 | Blueberry (DJ Short) | Thai × Purple Thai × Afghani | Blueberry sweetness, indica relaxation, purple phenotypes |
| Kushberry | OG Kush × Blueberry | DNA Genetics (Amsterdam) | Sweet blueberry-kush aroma, relaxing euphoria, 18–22% THC |
Kushberry’s terpene profile is a direct expression of its dual-parent heritage. The myrcene dominance inherited from both parents (OG Kush and Blueberry are both high-myrcene strains) creates the characteristic earthy-herbal base and the body relaxation depth. The linalool contribution from the Blueberry lineage adds a floral sweetness that blends with the myrcene to create the distinctive sweet-berry-earth aroma. The limonene from OG Kush adds a bright citrus-lift to the top note and contributes to the initial euphoric uplift.
| Compound | Typical Range | Effect Contribution | Aroma Note |
|---|---|---|---|
| THC | 18–22% | Euphoria, relaxation, pain relief, body stone | — |
| CBD | <0.5% | Minimal; slight anti-inflammatory baseline | — |
| Myrcene | High (>0.8%) | Body sedation, muscle relaxation, THC potentiation | Earthy, herbal, slightly musky |
| Linalool | Moderate (>0.4%) | Floral sweetness, GABA modulation, anxiety reduction, sedation | Floral, sweet, lavender-berry |
| Limonene | Moderate (>0.3%) | Mood elevation, anxiety reduction, initial euphoria | Citrus brightness, sweet |
| Caryophyllene | Low–Moderate | CB2 anti-inflammatory, stress reduction | Spice, pepper, kush note |
| Ocimene | Low | Uplifting, sweet aroma contribution | Sweet, herbal berry |
Kushberry delivers a well-structured, two-phase effect that reflects the balance between its OG Kush and Blueberry parents. The initial phase, beginning 10–15 minutes after consumption, is primarily cerebral: a warm, comfortable euphoria with mood elevation that carries the limonene brightness of the OG Kush lineage. Users feel sociable, positive, and mildly energised during this first phase without the racing quality of a pure sativa.
The second phase begins around 30–45 minutes in as the myrcene and linalool body effect deepens. The initial cerebral lift softens and is replaced by a progressive body relaxation that builds over the next hour. At standard doses, Kushberry reaches a comfortable plateau of mental ease and physical relaxation without full couch-lock — making it suitable for evening use where some mental engagement is still desired. At high doses, the body stone deepens into full sedation, and sleep onset becomes likely.
The mood-elevating quality of Kushberry persists through both phases — even as the body relaxes, the mental state remains positive and comfortable. This sustained positive mood is one of Kushberry’s most appreciated characteristics and distinguishes it from pure sedative indicas that suppress both body and mood equally.
The blueberry aroma that Kushberry inherits from its DJ Short Blueberry parent is striking on first encounter — sweet, fresh, and authentically berry-like in a way that many “berry” strains fail to deliver. This sweetness opens the aromatic experience before the deeper earthy-kush layer from the OG Kush parent emerges. The two layers coexist rather than compete: the blueberry sweetness provides the top note, the earthy-kush provides the body.
On the exhale, the transition from berry sweetness to earthy-kush depth is particularly satisfying. The finish carries a lingering sweet-earthy note that combines elements of both parents into something coherent and distinctive. Some phenotypes express more pronounced fuel undertones from the OG Kush lineage, while others maintain the berry-sweet character throughout — phenotype selection matters significantly in Kushberry’s flavour expression.
Kushberry is an excellent medical cannabis choice for conditions where balanced relaxation and mood elevation are both required. The combination of euphoric OG Kush character and deep body relaxation from the Blueberry lineage makes it effective for anxiety and depression simultaneously — conditions that frequently co-occur. The linalool content provides meaningful anxiolytic effect through GABA modulation, while the limonene-driven euphoria addresses low mood and anhedonia.
Chronic pain patients appreciate Kushberry for evening or night-time use. The progressive body stone provides genuine analgesic coverage without the heavy sedation of pure Afghani-derived strains, allowing for more functional use earlier in the evening. Insomnia patients find it effective at higher doses. PTSD symptoms — particularly hyperarousal and intrusive thought cycles — respond to the calming, mood-stabilising effect of the myrcene-linalool-limonene combination. Appetite stimulation is moderate and generally welcome for cancer patients or those with appetite disorders.
| Condition | Key Mechanism | Dose Range | Timing |
|---|---|---|---|
| Anxiety + depression (comorbid) | Limonene euphoria + Linalool GABA | Low–moderate | Evening preferred |
| Chronic pain | CB1 analgesia + Caryophyllene CB2 | Moderate | Evening / night |
| Insomnia | Myrcene + THC sedation at high dose | High | 30–60 min before sleep |
| PTSD | Myrcene + Linalool calming | Low–moderate | Evening use |
| Appetite | CB1 ghrelin pathway | Moderate | Before meals, evening |
Kushberry is a moderately easy grow that rewards growers who provide slightly above-average conditions. The indica dominance means plants remain manageable in height (80–110cm indoors) and do not require the significant vertical space management needed for sativa-dominant strains. The structure is typically bushy with multiple branching sites, responding well to topping or FIM to develop multiple colas rather than a single dominant apical.
Flower time of 8–9 weeks is typical for OG Kush crosses. The OG parent phenotypes may push toward 9 weeks while Blueberry-leaning phenotypes can finish closer to 8. The purple colouration that some Kushberry phenotypes express requires cold night temperatures (dropping to 10–15°C) during the last two weeks of flower to fully develop — growers who achieve this report spectacular visual results with deep purple hues against the orange pistils and white trichome frost.
Yields are solid but not exceptional: 400–500g/m² indoor under quality lighting. The buds are dense and resinous with a satisfying weight-to-size ratio. Humidity management during the last two weeks of flower is important — the dense bud structure inherited from the indica genetics creates conditions where botrytis (bud rot) can develop if airflow is insufficient and relative humidity exceeds 55%.
| Parameter | Indoor | Outdoor | Notes |
|---|---|---|---|
| Flower Time | 8–9 weeks | Late September–early October | OG phenos 9 weeks; Berry phenos 8 |
| Yield Indoor | 400–500g/m² | 500–700g/plant | Consistent; quality over bulk |
| Height | 80–110cm | 100–150cm | Manageable; responds well to topping |
| Difficulty | Moderate | Easy–Moderate | Some humidity management required |
| Purple Colour | Cold nights required | Natural cool nights ideal | Drop to 10–15°C last 2 weeks |
| Humidity | Max 55% RH in flower | Prefers dry climate | Dense buds vulnerable to botrytis |
Kushberry’s complex berry-kush terpene profile is best experienced through vaporisation at 170–185°C, which allows the linalool and limonene notes to shine before the myrcene earth base takes over at higher temperatures. The contrast between the sweet opening and earthy finish is one of the pleasures of a well-grown Kushberry experience. Combustion smoking in joints preserves the full spectrum but sacrifices some of the delicate linalool sweetness.
As a concentrate source, Kushberry live resin is outstanding — the berry-sweet-kush terpene profile translates directly into the concentrate and delivers an exceptional flavour experience alongside the reliable indica relaxation effect. Edible preparation from Kushberry-infused oil is increasingly popular among medical users who prefer precise dosing for pain and sleep management.
Kushberry is an indica-dominant hybrid (approximately 70/30) created by DNA Genetics in Amsterdam, crossing OG Kush with DJ Short’s Blueberry. It delivers blueberry-sweet-earthy-kush aromas, relaxing euphoric effects, and THC of 18–22%. It is one of the most successful OG-berry crosses from a respected breeding programme with multiple Cannabis Cup recognition.
Kushberry produces a two-phase effect: an initial cerebral euphoria and mood elevation (from OG Kush lineage) followed by progressive body relaxation deepening over 60–90 minutes. At standard doses, it reaches a comfortable plateau of mental ease and physical relaxation without full couch-lock. At high doses, sedation deepens toward sleep onset. Sustained positive mood throughout both phases is a defining characteristic.
Kushberry has a distinct dual-layer aroma: fresh blueberry sweetness from the Blueberry parent opens the profile, followed by the deeper earthy-kush substrate from the OG Kush parent. The exhale transitions from berry sweetness to earthy-kush depth with a lingering sweet-earth finish. Some phenotypes express more fuel undertones from OG Kush; others maintain the berry-sweet character throughout. Best experienced through vaporisation at 170–185°C.
Kushberry can be effective for anxiety, particularly when comorbid with depression or low mood. The linalool content provides GABA-mediated anxiolytic effect, while the limonene contributes mood elevation. However, users highly sensitive to THC-induced anxiety should approach with caution and start with low doses, as the 18–22% THC can amplify anxiety at high doses without adequate tolerance.